Literature DB >> 22157623

Liver fibrosis: mechanisms of immune-mediated liver injury.

Ruonan Xu1, Zheng Zhang, Fu-Sheng Wang.   

Abstract

Liver fibrosis and its end-stage consequence, cirrhosis, represent the final common pathway of virtually all chronic liver diseases. Research into hepatic stellate cell activation, imbalance of the extracellular matrix synthesis and degradation and the contribution of cytokines and chemokines has further elucidated the mechanisms underlying fibrosis. Furthermore, clarification of changes in host adaptive and innate immune systems has accelerated our understanding of the association between liver inflammation and fibrosis. Continued elucidation of the mechanisms of hepatic fibrosis has provided a comprehensive model of fibrosis progression and regression. This review summarizes the current concepts of improvements that have been made in the field of fibrosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22157623      PMCID: PMC4132585          DOI: 10.1038/cmi.2011.53

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  59 in total

Review 1.  Cirrhosis reversal: a duel between dogma and myth.

Authors:  Valeer J Desmet; Tania Roskams
Journal:  J Hepatol       Date:  2004-05       Impact factor: 25.083

Review 2.  Hepatic stem cells: from inside and outside the liver?

Authors:  M R Alison; P Vig; F Russo; B W Bigger; E Amofah; M Themis; S Forbes
Journal:  Cell Prolif       Date:  2004-02       Impact factor: 6.831

3.  Isolation and cultivation of rat liver stellate cells.

Authors:  R Blomhoff; T Berg
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

Review 4.  Macrophage diversity in renal injury and repair.

Authors:  Sharon D Ricardo; Harry van Goor; Allison A Eddy
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

5.  TLR4 enhances TGF-beta signaling and hepatic fibrosis.

Authors:  Ekihiro Seki; Samuele De Minicis; Christoph H Osterreicher; Johannes Kluwe; Yosuke Osawa; David A Brenner; Robert F Schwabe
Journal:  Nat Med       Date:  2007-10-21       Impact factor: 53.440

6.  Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis.

Authors:  A W Cheever; M E Williams; T A Wynn; F D Finkelman; R A Seder; T M Cox; S Hieny; P Caspar; A Sher
Journal:  J Immunol       Date:  1994-07-15       Impact factor: 5.422

7.  Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration.

Authors:  Robert F Schwabe; Ramon Bataller; David A Brenner
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-06-26       Impact factor: 4.052

8.  Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis.

Authors:  Pavel Taimr; Hajime Higuchi; Eva Kocova; Richard A Rippe; Scott Friedman; Gregory J Gores
Journal:  Hepatology       Date:  2003-01       Impact factor: 17.425

9.  Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage.

Authors:  Claire Dunn; Maurizia Brunetto; Gary Reynolds; Theodoros Christophides; Patrick T Kennedy; Pietro Lampertico; Abhishek Das; A Ross Lopes; Persephone Borrow; Kevin Williams; Elizabeth Humphreys; Simon Afford; David H Adams; Antonio Bertoletti; Mala K Maini
Journal:  J Exp Med       Date:  2007-03-12       Impact factor: 14.307

Review 10.  Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets.

Authors:  A M Gressner; R Weiskirchen
Journal:  J Cell Mol Med       Date:  2006 Jan-Mar       Impact factor: 5.310

View more
  64 in total

1.  Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis.

Authors:  Maria Eduarda Rocha de França; Sura Wanessa Santos Rocha; Wilma Helena Oliveira; Laise Aline Santos; Anne Gabrielle Vasconcelos de Oliveira; Karla Patrícia Sousa Barbosa; Ana Karolina Santana Nunes; Gabriel Barros Rodrigues; Deniele Bezerra Lós; Christina Alves Peixoto
Journal:  Inflammopharmacology       Date:  2017-04-13       Impact factor: 4.473

2.  Precision-cut human liver slice cultures as an immunological platform.

Authors:  Xia Wu; Jessica B Roberto; Allison Knupp; Heidi L Kenerson; Camtu D Truong; Sebastian Y Yuen; Katherine J Brempelis; Marianne Tuefferd; Antony Chen; Helen Horton; Raymond S Yeung; Ian N Crispe
Journal:  J Immunol Methods       Date:  2018-02-01       Impact factor: 2.303

Review 3.  Restoring homeostasis of CD4⁺ T cells in hepatitis-B-virus-related liver fibrosis.

Authors:  Li-Sha Cheng; Yun Liu; Wei Jiang
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

4.  Hepatitis B virus inhibits insulin receptor signaling and impairs liver regeneration via intracellular retention of the insulin receptor.

Authors:  Sebastian Robert Barthel; Regina Medvedev; Thekla Heinrich; Sarah Manon Büchner; Nadja Kettern; Eberhard Hildt
Journal:  Cell Mol Life Sci       Date:  2016-05-07       Impact factor: 9.261

5.  A bioactive product lipoxin A4 attenuates liver fibrosis in an experimental model by regulating immune response and modulating the expression of regeneration genes.

Authors:  Elçin Latife Kurtoğlu; Başak Kayhan; Mehmet Gül; Burçak Kayhan; Meral Akdoğan Kayhan; Zeynal Mete Karaca; Elif Yeşilada; Sezai Yılmaz
Journal:  Turk J Gastroenterol       Date:  2019-08       Impact factor: 1.852

6.  Implantation of healthy matrix-embedded endothelial cells rescues dysfunctional endothelium and ischaemic tissue in liver engraftment.

Authors:  Pedro Melgar-Lesmes; Mercedes Balcells; Elazer R Edelman
Journal:  Gut       Date:  2016-02-05       Impact factor: 23.059

7.  Cathepsin B deficiency ameliorates liver lipid deposition, inflammatory cell infiltration, and fibrosis after diet-induced nonalcoholic steatohepatitis.

Authors:  Wenqian Fang; Zhiyong Deng; Feriel Benadjaoud; Chongzhe Yang; Guo-Ping Shi
Journal:  Transl Res       Date:  2020-05-11       Impact factor: 7.012

8.  Genistein improves schistosomiasis liver granuloma and fibrosis via dampening NF-kB signaling in mice.

Authors:  Chunpeng Wan; Fen Jin; Youqin Du; Kang Yang; Liangliang Yao; Zhigang Mei; Weifeng Huang
Journal:  Parasitol Res       Date:  2017-02-03       Impact factor: 2.289

9.  Using immunoproteomics to identify alpha-enolase as an autoantigen in liver fibrosis.

Authors:  Bo Peng; Xueyong Huang; Ernesto S Nakayasu; John R Petersen; Suimin Qiu; Igor C Almeida; Jian-Ying Zhang
Journal:  J Proteome Res       Date:  2013-03-15       Impact factor: 4.466

10.  Association of serum zinc levels with liver function and survival in patients awaiting liver transplantation.

Authors:  Kilian Friedrich; Carina Baumann; Maik Brune; Andreas Wannhoff; Christian Rupp; Sabine G Scholl; Christoph Antoni; Matthias Dollinger; Christoph Neumann-Haefelin; Karl Heinz Weiss; Wolfgang Stremmel; Peter Schemmer; Daniel Nils Gotthardt
Journal:  Langenbecks Arch Surg       Date:  2015-08-26       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.